Catalyst Pharmaceutical Partners, Inc. 4/A
4/A · Catalyst Pharmaceutical Partners, Inc. · Filed Oct 22, 2009
Insider Transaction Report
Form 4/AAmended
Weinstein Jack
V.P., Treasurer & CFO
Transactions
- Expiration (Short)
Options to purchase common stock
2009-10-20−145,922→ 306,842 totalExercise: $2.98Exp: 2010-03-04→ Common Stock (145,922 underlying) - Award
Options to purchase common stock
2009-10-20+41,666→ 348,508 totalExercise: $0.90From: 2009-10-20Exp: 2014-10-20→ Common Stock (41,666 underlying) - Award
Options to purchase common stock
2009-10-20+41,667→ 390,175 totalExercise: $0.90From: 2010-10-20Exp: 2014-10-20→ Common Stock (41,667 underlying) - Award
Options to purchase common stock
2009-10-20+41,667→ 431,842 totalExercise: $0.90From: 2011-10-20Exp: 2014-10-20→ Common Stock (41,667 underlying)
Footnotes (3)
- [F1]Options were cancelled pursuant to the above-described grant.
- [F2]Current.
- [F3]This Form 4 has been amended to correct an error in the price of the derivative security.